Drugs
Controller General of India ("DGCI") to import and market, Linagliptin Tablet and FDC
of Linagliptin + Metformin Hydrochloride tablets which is the formulation ... Linagliptin'.
4. OP-1 holds two patents bearing nos. IN 227719 under the title "Xanthine Compounds"
which was valid for a period
Moxifloxacin
hydrochloride 8) Loxoprofen sodium hydrate 9) Voglibose
10)Olmesartan medoxomil 11) Linagliptin 12) Warfarin sodium
shall not be carried on unless HARA and HAZOP
Moxifloxacin
hydrochloride 8) Loxoprofen sodium hydrate 9) Voglibose
10)Olmesartan medoxomil 11) Linagliptin 12) Warfarin sodium
shall not be carried on unless HARA and HAZOP
Moxifloxacin
hydrochloride 8) Loxoprofen sodium hydrate 9) Voglibose
10)Olmesartan medoxomil 11) Linagliptin 12) Warfarin sodium
shall not be carried on unless HARA and HAZOP
Moxifloxacin
hydrochloride 8) Loxoprofen sodium hydrate 9) Voglibose
10)Olmesartan medoxomil 11) Linagliptin 12) Warfarin sodium
shall not be carried on unless HARA and HAZOP
